Cross cultural adaptation of the Greek sarcopenia quality of life (SarQoL) questionnaire

[en] Purpose: To translate and validate into the Greek language and setting the Sarcopenia Quality of Life (SarQoL®) questionnaire. Methods: A convenience sample of 176 Greek elderly people (136 females, 40 males; aged 71.19 ± 7.95 years) was recruited, 50 of which (36 females, 14 males) were diagnosed sarcopenic. Questionnaire was back-translated and culturally adapted into Greek according to international guidelines. To validate the Greek SarQoL®, we assessed its validity (discriminative power, construct validity), reliability (internal consistency, test–retest reliability) and floor/ceiling effects. Participants were divided into sarcopenic and non-sarcopenic. Sarcopenic subjects apart from the Greek SarQoL (SarQoLGR) filled out the Greek versions of two generic questionnaires; Short Form-36 and EuroQoL 5-dimension. Results: The Greek SarQoL questionnaire was translated without major difficulties. SarQoLGR mean scores were 52.12 ± 11.04 (range: 24.74–71.81) for sarcopenic subjects and 68.23 ± 14.1 (range: 24.83–94.81) for non-sarcopenic ones. Results indicated good discriminative power across sarcopenic and non-sarcopenic subjects (p = 0.01), high internal consistency (Cronbach’s alpha of 0.96) and excellent test–retest reliability (ICC = 0.96, 95% CI = 0.95–0.97). Neither a floor nor a ceiling effect was observed. Conclusions: The Greek SarQoL was found to be a reliable and valid measure of quality of life for sarcopenic patients. It is therefore, available for use in future clinical research and practice.Implications for rehabilitation The Greek version of the SarQoL® questionnaire is a valid and reliable outcome measure for assessing patients with sarcopenia. The Greek SarQoL is recommended to be use in clinical settings and research. The Greek SarQoL® questionnaire is available online www.sarqol.org. © 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group.

Disciplines :

Public health, health care sciences & services

Author, co-author :

Tsekoura, M.; Department of Physiotherapy, School of Health and Caring Professions, Technological Educational Institute (ΤΕΙ) of Western Greece, Aigio, Greece

Billis, E.; Department of Physiotherapy, School of Health and Caring Professions, Technological Educational Institute (ΤΕΙ) of Western Greece, Aigio, Greece

Gliatis, J.; Department of Orthopaedic Surgery, University Hospital of Patras, Rio, Greece

Tsepis, E.; Department of Physiotherapy, School of Health and Caring Professions, Technological Educational Institute (ΤΕΙ) of Western Greece, Aigio, Greece

Matzaroglou, C.; Department of Physiotherapy, School of Health and Caring Professions, Technological Educational Institute (ΤΕΙ) of Western Greece, Aigio, Greece

Sakkas, G. K.; Faculty of Sport and Health Sciences, University of St Mark & St John, Plymouth, United Kingdom

Beaudart, Charlotte ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé

Bruyère, Olivier ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé

Tyllianakis, M.; Department of Orthopaedic Surgery, University Hospital of Patras, Rio, Greece

Panagiotopoulos, E.; Department of Spinal Cord Injuries, University Hospital of Patras, Rio, Greece

Language :

English

Title :

Cross cultural adaptation of the Greek sarcopenia quality of life (SarQoL) questionnaire

Publication date :

2020

Journal title :

Disability and Rehabilitation

ISSN :

0963-8288

eISSN :

1464-5165

Publisher :

Taylor and Francis Ltd

Volume :

Issue :

Pages :

1006-1012

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 05 June 2019

Statistics

Number of views

44 (9 by ULiège)

Number of downloads

3 (2 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in older people. Age Ageing. 2010;39:412–423.
Delmonico MJ, Harris TB, Lee JS, et al. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc. 2007;55:769–774.
Tsekoura M, Gliatis J, Billis E. Sarcopenia: update of the literature. Arch Hellenic Med. 2017;34:42–48.
Beaudart C, Biver E, Reginster JY, et al. Development of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects: the SarQoL. Age Ageing. 2015;44:960–966.
Rizzoli R, Reginster JY, Arnal JF, et al. Quality of life in sarcopenia and frailty. Calcif Tissue Int. 2013;93:101–120.
Tsekoura M, Kastrinis A, Katsoulaki M, et al. Sarcopenia and its impact on Quality of life: a literature review. Switzerland: Springer?s Advances in Experimental Medicine and Biology (AEMB); 2017. p. 213–218.
Higginson IJ, Carr AJ. Measuring quality of life: using quality of life measures in the clinical setting. Bmj. 2001;322:1297–1300.
Beaudart C, Reginster JY, Geerinck A, et al. Current review of the SarQoL®: a health-related quality of life questionnaire specific to sarcopenia. Expert Rev Pharmacoecon Outcomes Res. 2017;17:335–341.
Beaudart C, Biver E, Reginster J-Y, et al. Validation of the SarQoL, a specific health-related quality of life questionnaire for Sarcopenia. J Cachexia Sarcopenia Muscle. 2017;8:238–244.
Beaudart C, Edwards M, Moss C, et al. English translation and validation of the SarQoL®, a quality of life questionnaire specific for sarcopenia. Age Ageing. 2017;46:271–276.
Gasparik AI, Mihai G, Beaudart C, et al. Psychometric performance of the Romanian version of the SarQoL®, a health-related quality of life questionnaire for sarcopenia. Arch Osteoporos. 2017;12:103.
Beaudart C, Biver E, Reginster J-Y, et al. Translation and validation of the Dutch SarQoL®, a quality of life questionnaire specific to sarcopenia. J Musculoskelet Neuronal Interact. 2017;8:238.
http://www.sarqol.org
Tsekoura M, Billis E, Matzaroglou C, et al. Investigation on the prevalence of Sarcopenia and related factors in elderly living in Achaia-Greece.World Conference on Osteoporosis Osteoarthritis and Musculoskeletal Diseases. Οsteoporosis International. 2017;28:1.
Rolland Y, Lauwers-Cances V, Cristini C, et al. Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l’OSteoporose) Study. Am J Clin Nutr. 2009;89:1895–1900.
Bahat G, Tufan A, Tufan F, et al. Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition. Clin Nutr. 2016;35:1557–1563.
Terwee CB, Bot SDM, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60:34–42.
Golafshani N. Understanding reliability and validity in qualitative research. Qualitative Report 2003;8:597–607.
Heale R, Twycross A. Validity and reliability in quantitative studies. Evid Based Nurs. 2015;18: 66–67.
Pappa E, Kontodimopoulos N, Niakas D. Validating and norming of the Greek SF-36 Health Survey. Qual Life Res. 2005;14:1433–1438.
Yfantopoulos J. The Greek Version of the EuroQol (EQ-5D) Instrument. Arch Hellenic Med. 2001;18:180–191.
Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33:337–343.
Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age and Ageing. 2014;43:748.
TK, Koo MY, Li A. Guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15:155–163.
Munro B. Statistical methods for health care research (5th ed.). Philadelphia: Lippincott Williams and Wilkins; 2005. p. 239–259.
Nunnally JCBI. Psychometric theory. New York: McGrawHill Inc; 1994. Available from: http://www.amazon.com/Psychometric‐Theory‐Jum‐C‐Nunnally/dp/007047849X
Beaudart C, Reginster JY, Petermans J, et al. Quality of life and physical components linked to sarcopenia: The SarcoPhAge study. Exp Gerontol. 2015;69:103–110.
Morishita S, Kaida K, Tanaka T, et al. Prevalence of sarcopenia and relevance of body composition, physiological function, fatigue, and health-related quality of life in patients before allogeneic hematopoietic stem cell transplantation. Support Care Cancer. 2012;20:3161–3318.
Juniper EF, Gordon HG, Roman J. How to develop and validate a new health-related quality of life instrument. In Quality of Life and Pharmacoeconomics in Clinical Trials. 2nd edition. B., Spilker editor. Philadelphia (PA): Lippincott-Raven Publishers; 1996. p. 49–56.
Sarfati D. How Do We Measure Comorbidity? Springer Science + Business Media Singapore. B., Koczwara editor. Australia: Cancer and Chronic Conditions; 2016. p. 35–70.
Barrera-Ariza L, Gonzalez- Correa CH, Gonzalez-Correa CA. Quality of reporting of bioelectrical impedance analysis (BIA) studies evaluating body fluid volumes: The need for standardization. World Congress on Medical Physics and Biomedical Engineering, IFMBE Proceedings 25/VII, Munich; 2009. p. 244–246.
Tsekoura M, Billis E, Gliatis J, et al. Assessment of muscle mass for elderly population in clinical practice. Arch Hellenic Med. 2017;34:745–753.
Kim KM, Jang HC, Lim S. Differences among skeletal muscle mass indices derived from height-, weight-, and body mass indexadjusted models in assessing sarcopenia. Korean J Intern Med. 2016;31:643–650.
Buckinx F, Landi F, Cesari M, et al. Pitfalls in the measurement of muscle mass: a need for a reference standard. J Cachexia Sarcopenia Muscle. 2018;9:269–278.
Deurenberg P, Pietrobelli A, Wang ZM, et al. Prediction of total body skeletal muscle mass from fat-free mass or intra-cellular water. Int J Body Compos Res. 2004;2:107e13.
Gonzalez MC, Heymsfield SB. Bioelectrical impedance analysis for diagnosing sarcopenia and cachexia: what are we really estimating? Journal of Cachexia, Sarcopenia and Muscle. 2017;8:187–189.